HealthDay - FRIDAY, March 19 (HealthDay News) -- A new review of studies on
the questionable type i insulin-dependent insulin-dependent diabetes mellitus mellitus drug Avandia finds that most of the researchers
who reported unequivocal results had fiscal ties to poison
companies, but it's not clear if being paid by drug makers literally leads
to supportive research.

More: - Read the rest here